← back to search

Gang Zhu

Harbin Medical University · CN
🔎 Find collaborators in Pharmacology · Cellular and Molecular Neuroscience →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pharmacology · Cellular and Molecular Neuroscience
Research interest
Research focused on Major depressive disorder and Cognition, with related work in Stroop effect, Depression (economics), Tolerability. Notable publications include 'The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled Trials', 'Major depressive disorder comorbid with general anxiety disorder: Associations among neuroticism, adult stress, and the inflammatory index', and 'The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study'.
h-index
citations
363
works
16
NIH funding
primary concept
email

Recent publications

Associations between age of onset and domain-specific cognitive deficits in major depressive disorder
Journal of Affective Disorders 2025cited by 0position: middledoi
Latent classes of symptom trajectories among major depressive disorder patients in China
Journal of Affective Disorders 2024cited by 5position: middledoi
Proinflammatory phenotype in major depressive disorder with adulthood adversity: In line with social signal transduction theory of depression
Journal of Affective Disorders 2023cited by 7position: middledoi
Major depressive disorder comorbid with general anxiety disorder: Associations among neuroticism, adult stress, and the inflammatory index
Journal of Psychiatric Research 2022cited by 36position: middledoi
The Chinese Brief Cognitive Test: Normative Data Stratified by Gender, Age and Education
Frontiers in Psychiatry 2022cited by 24position: middledoi
Features of cognitive impairment and related risk factors in patients with major depressive disorder: A case-control study
Journal of Affective Disorders 2022cited by 16position: middledoi
The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study
Journal of Psychiatric Research 2021cited by 35position: middledoi
Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder
Psychiatry Research 2021cited by 19position: middledoi
Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment
Journal of Affective Disorders 2021cited by 16position: middledoi
Neurocognitive profiles of patients with first-episode and recurrent depression: a cross-sectional comparative study from China
Journal of Affective Disorders 2021cited by 14position: middledoi
Research on Cognitive Function in Anxious Depression Patients in China
Journal of Affective Disorders 2020cited by 28position: middledoi
Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder
Journal of Psychiatric Research 2020cited by 19position: middledoi
Demographic and Psychosocial Variables Could Predict the Occurrence of Major Depressive Disorder, but Not the Severity of Depression in Patients with First-episode Major Depressive Disorder in China
Journal of Affective Disorders 2020cited by 17position: middledoi
Research progress of malignant phenotypic transcription factors in colorectal cancer
Int J Genet 2020cited by 0position: firstdoi
The effect of short-term use of benzodiazepines on cognitive function of major depressive disorder patients being treated with antidepressants
Journal of Affective Disorders 2019cited by 18position: middledoi
MiRNA-409-3p enhances cisplatin-sensitivity of ovarian cancer cells by blocking the autophagy mediated by Fip200
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018cited by 32position: middledoi
Sei-1 promotes double minute chromosomes formation through activation of the PI3K/Akt/BRCA1-Abraxas pathway and induces double-strand breaks in NIH-3T3 fibroblasts
Cell Death and Disease 2018cited by 12position: middledoi
MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells
Molecules and Cells 2016cited by 28position: middledoi
The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled Trials
Journal of Alzheimer s Disease 2014cited by 107position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Kerang Zhang · Shanxi Medical University13 papers (2019–2025)Jing Wei · Fudan University13 papers (2019–2025)Xin Yu · Kunming University of Science and Technology12 papers (2019–2025)Hongjun Tian · Anhui Medical University11 papers (2020–2025)Nan Zhang · Stanford University11 papers (2020–2025)Xueyi Wang · Hebei Medical University11 papers (2020–2025)Tianmei Si · Wenzhou Medical University10 papers (2020–2025)Qiaoling Chen · Anhui Medical University10 papers (2020–2025)Xiaozhen Lv · Xinjiang University8 papers (2020–2023) · 5 papers (2020–2025)Gang Wang · Harbin Medical University5 papers (2021–2025)Yü Huang · Tung Wah College4 papers (2020–2021) · 4 papers (2021–2022)Jingyu Lin · Weifang Medical University4 papers (2020–2023)Chuan Shi · Chinese PLA General Hospital4 papers (2021–2025)Jing Jiang · Harbin Medical University3 papers (2019–2024)Yinan Jiang · Chongqing Jiaotong University3 papers (2019–2024) · 3 papers (2019–2024) · 3 papers (2019–2024)Jinya Cao · Fudan University3 papers (2019–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pharmacology · Cellular and Molecular Neuroscience →